Rua Bioscience first NZX IPO of the year

Rua Bioscience first NZX IPO of the year
Brent Melville
Rua Bioscience chair Trevor Burt says the pharmaceutical grade cannabis firm will seek to raise $20 million via a listing on the NZX on Oct. 22 in the first initial public offering of the year. The East Coast based firm - an early recipient for a commercial medicinal production licence - will sell up to 40 million shares at 50 cents a share, representing 28.6 percent of the company in what will be the NZX's first IPO since Napier Port listed last year and the second cannabis firm, following Cannasouth's debut last June. Rua wi...

More Listed Companies

How ‘shareholder value’ became a Wall Street mantra
Policy

How ‘shareholder value’ became a Wall Street mantra

Michael Jensen inspired the transformation of capitalism. Was he a hero or a villain?

Bloomberg 13 Apr 2024
How many boards should a director sit on?
Listed Companies

Simon Robertson: How many boards should a director sit on?

An attempt to judge the composition trends in NZX boards is challenging.

Simon Robertson 13 Apr 2024
Wellington council picks Precinct for major civic square project
Property

Wellington council picks Precinct for major civic square project

Firm will fund and build the new five-star green building.

Staff reporters 11 Apr 2024
Numbers and letters for investors
Markets

Simon Robertson: Numbers and letters for investors

A plea for standardised financial reporting from NZX-listed companies.

Simon Robertson 02 Mar 2024